我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
隶属于 NATIONAL HEALTH SERVICE
相关临床试验
2
2 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
N/A
进行中(未招募)
100.0%
暂无批准数据
- The NHS is trialling a 15-minute blood test called MeMed BV that can rapidly distinguish between bacterial and viral infections in children, potentially saving lives by enabling faster treatment decisions for conditions like sepsis and meningitis. - The test is being evaluated at three major children's hospitals and has already demonstrated clinical benefits, with cases showing accelerated treatment for meningococcal meningitis and sepsis patients receiving immediate antibiotic therapy. - Experts estimate the technology could save dozens of young lives annually, as approximately 500 children die each year from infections with suboptimal care occurring in 40% of cases. - The rapid diagnostic tool aims to reduce unnecessary antibiotic use while ensuring critically ill children receive immediate treatment, addressing both antimicrobial resistance concerns and clinical outcomes.